Archives: Speakers

Anders Nordell is the CEO and Co-Founder of Collective Minds. With a career spanning medical imaging science at Stanford and Karolinska to leadership roles at GE Healthcare, Anders now leads Collective Minds in its mission to break down healthcare silos. His work focuses on leveraging secure, cloud-native platforms to connect hospitals and researchers, accelerating the development of AI-powered diagnostics and therapies through real-world imaging data

Jonathan Wogel is CEO at NWEH and a senior life sciences leader with more than 35 years’ experience across the pharmaceutical, medical device, and biotech sectors. He has supported the launch and licensing of more than 50 products globally and specialises in business growth, investment strategy, and commercialisation. Jonathan has extensive experience supporting SMEs and is passionate about innovation in life sciences, mentorship, and commercialising cutting-edge technologies.

Steve Clark is a Patient Advocate and Patient Engagement Consultant as well as a Health and Healthcare Communicator, with over 45 years healthcare experience working in the NHS and pharmaceutical industry.

Since being diagnosed with stage 4 colorectal cancer in 2013 Steve has become an active patient advocate. He is a regular speaker at conferences and congresses, publication author and patient representative to several studies and study groups in the universities of Oxford, Liverpool, Edinburgh and Kings College London.

In 2017 he set up www.StriveForFive.org, a not-for-profit organization with the mission to give hope to fellow stage 4 cancer patients and to advocate for improved care for those with advanced cancer

20+ years of biotech finance experience working in FP&A, and clinical finance roles. His career started in Big-Pharma and has shifted to small and mid-sized Pharma companies the past several years. Expertise: R&D (Pre-clinical/Clinical/CMO) FP&A. clinical trial finance modeling & accounting, budgeting & forecasting, long range planning , revenue forecasting, financial systems (Hyperion, Oracle, SAP, Netsuite, MS D365, Anaplan, Adaptive Planning, R&D Logic, Great Plains), finance process improvement, business partnering.

With over 15 years of progressive experience in the field, I have successfully led global clinical studies across various phases and therapeutic areas, including complex protocols and accelerated development programs. My core competencies include clinical strategy, study management, vendor oversight, budget control, regulatory compliance, and cross-functional collaboration. I am passionate about advancing innovative immunotherapies for cancer patients and delivering high-quality clinical data and outcomes.

Jacqueline Smith, RPh, is a pharmacist and endometrial and ovarian cancer survivor committed to improving patient outcomes. Drawing on her pharmacy background, she champions federal research funding, treatment innovation, early detection, and public awareness for ovarian cancer. Jackie holds leadership roles with national and state ovarian cancer organizations, presents at major gynecologic oncology conferences, and serves as a research reviewer for the Congressionally Directed Medical Research Programs (CDMRP). Jackie is also a coauthor of a Gynecologic Oncology publication on patient-researcher collaboration and a member of the AACR Scientist↔Survivor Program®.